Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus

Metabolism: Clinical and Experimental
Anne E BantleJohn P Bantle

Abstract

Moderate alcohol consumption is associated with reduced cardiovascular disease rates in nondiabetic populations. However, the effects of alcohol in people with diabetes are not well defined. Accordingly, we tested the hypothesis that alcohol would raise plasma high-density lipoprotein (HDL) cholesterol or have other beneficial metabolic effects in persons with type 2 diabetes mellitus. To assess the acute effects of alcohol on plasma glucose and serum insulin, subjects were inpatients for 2 days during which they received, in random order, 240 mL wine or grape juice with their evening meal. To assess the chronic effects of alcohol on fasting plasma lipids, subjects consumed, in random order, 120 to 240 mL wine daily for 30 days and abstained from alcohol for 30 days. Participants were 18 non-insulin-treated volunteers with type 2 diabetes mellitus. Acutely, 240 mL wine containing 24 g alcohol had no effect on plasma glucose or serum insulin. Chronically, wine consumption for 30 days (mean consumption, 18 g alcohol per day) compared with abstinence for 30 days resulted, respectively, in mean +/- SEM fasting plasma cholesterol of 160 +/- 6 and 160 +/- 8 mg/dL (P = .98), HDL cholesterol of 47 +/- 3 and 46 +/- 3 mg/dL (P = .87), lo...Continue Reading

References

Oct 19, 1995·The New England Journal of Medicine·E J SijbrandsR G Westendorp
May 11, 1995·The New England Journal of Medicine·C S FuchsB Rosner
Nov 24, 1999·The New England Journal of Medicine·K BergerC H Hennekens
Feb 6, 2002·Annals of Internal Medicine·Craig R WalshDaniel Levy
Jan 10, 2003·The New England Journal of Medicine·Kenneth J MukamalEric B Rimm
Oct 22, 2003·Annals of Internal Medicine·Jennifer Fisher Wilson
Feb 6, 2004·Annals of Internal Medicine·Andrea A HowardMarc N Gourevitch
Nov 25, 2005·Diabetes Care·Joline W J BeulensMichiel L Bots

❮ Previous
Next ❯

Citations

Jun 10, 2010·Acta Diabetologica·Patricia A EnglerRobert J Smith
Feb 19, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Ichiro Wakabayashi
Nov 4, 2011·The American Journal of Clinical Nutrition·Rania A MekaryFrank B Hu
Sep 10, 2013·Endocrinology and Metabolism Clinics of North America·Nadia Rachdaoui, Dipak K Sarkar
May 16, 2014·Canadian Journal of Diabetes·Paula D DworatzekSandra L Williams
Jun 18, 2010·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A PietraszekK Hermansen
May 23, 2009·Annals of Epidemiology·Wenjie SunGabriel M Leung
Apr 17, 2012·Journal of the Science of Food and Agriculture·Creina S Stockley
Mar 1, 2011·Metabolism: Clinical and Experimental·Michel M JoostenHenk F J Hendriks
Dec 21, 2013·Diabetes Care·Alison B EvertWilliam S Yancy
Dec 21, 2013·Diabetes·R Paul Robertson
Oct 11, 2013·Diabetes Care·Alison B EvertUNKNOWN American Diabetes Association
Dec 3, 2014·Maturitas·Ana ArteroAntonio Cano
Apr 20, 2019·Diabetes Care·Alison B EvertWilliam S Yancy
Jan 1, 2009·Substance Abuse : Research and Treatment·Susan E Ramsey, Patricia A Engler
Nov 1, 2012·Expert Review of Endocrinology & Metabolism·Marion J Franz
May 22, 2019·Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence·F GigantiM P Viggiano

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.